miR-7 Restores Phenotypes in Myotonic Dystrophy Muscle Cells by Repressing Hyperactivated Autophagy
Open Access
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 19, 278-292
Abstract
No abstract availableKeywords
Funding Information
- Ministerio de Economía y Competitividad (SAF2015-64500-R)
- Ministerio de Ciencia, Innovación y Universidades (RTI2018-094599-B-100)
- European Regional Development Fund
- Generalitat Valenciana
- ERDF (APOSTD2017/077, ACIF/2018/071)
- Conselleria d'Educació, Investigació, Cultura i Esport
This publication has 51 references indexed in Scilit:
- Cellular and molecular mechanisms of muscle atrophyDisease Models & Mechanisms, 2013
- Molecular, Physiological, and Motor Performance Defects in DMSXL Mice Carrying >1,000 CTG Repeats from the Human DM1 LocusPLOS Genetics, 2012
- GSK3β mediates muscle pathology in myotonic dystrophyJournal of Clinical Investigation, 2012
- eEF-2 Kinase Dictates Cross-Talk between Autophagy and Apoptosis Induced by Akt Inhibition, Thereby Modulating Cytotoxicity of Novel Akt Inhibitor MK-2206Cancer Research, 2011
- Therapeutics development in myotonic dystrophy type 1Muscle & Nerve, 2011
- miRTarBase: a database curates experimentally validated microRNA–target interactionsNucleic Acids Research, 2010
- Autophagy in health and disease. 3. Involvement of autophagy in muscle atrophyAmerican Journal of Physiology-Cell Physiology, 2010
- Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patientsJournal of Translational Medicine, 2010
- Increased Steady-State Levels of CUGBP1 in Myotonic Dystrophy 1 Are Due to PKC-Mediated HyperphosphorylationMolecular Cell, 2007
- Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophyProceedings of the National Academy of Sciences, 2006